Cargando…

Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals

Detalles Bibliográficos
Autores principales: Zhai, Wei, Li, Saiyang, Zhang, Jin, Chen, Yonghui, Ma, Junjie, Kong, Wen, Gong, Dongkui, Zheng, Junhua, Xue, Wei, Xu, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985374/
https://www.ncbi.nlm.nih.gov/pubmed/35387658
http://dx.doi.org/10.1186/s12943-022-01568-y
_version_ 1784682353494327296
author Zhai, Wei
Li, Saiyang
Zhang, Jin
Chen, Yonghui
Ma, Junjie
Kong, Wen
Gong, Dongkui
Zheng, Junhua
Xue, Wei
Xu, Yunfei
author_facet Zhai, Wei
Li, Saiyang
Zhang, Jin
Chen, Yonghui
Ma, Junjie
Kong, Wen
Gong, Dongkui
Zheng, Junhua
Xue, Wei
Xu, Yunfei
author_sort Zhai, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-8985374
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89853742022-04-07 Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals Zhai, Wei Li, Saiyang Zhang, Jin Chen, Yonghui Ma, Junjie Kong, Wen Gong, Dongkui Zheng, Junhua Xue, Wei Xu, Yunfei Mol Cancer Correction BioMed Central 2022-04-06 /pmc/articles/PMC8985374/ /pubmed/35387658 http://dx.doi.org/10.1186/s12943-022-01568-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Zhai, Wei
Li, Saiyang
Zhang, Jin
Chen, Yonghui
Ma, Junjie
Kong, Wen
Gong, Dongkui
Zheng, Junhua
Xue, Wei
Xu, Yunfei
Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
title Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
title_full Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
title_fullStr Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
title_full_unstemmed Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
title_short Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
title_sort correction to: sunitinib-suppressed mir-452-5p facilitates renal cancer cell invasion and metastasis through modulating smad4/smad7 signals
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985374/
https://www.ncbi.nlm.nih.gov/pubmed/35387658
http://dx.doi.org/10.1186/s12943-022-01568-y
work_keys_str_mv AT zhaiwei correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT lisaiyang correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT zhangjin correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT chenyonghui correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT majunjie correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT kongwen correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT gongdongkui correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT zhengjunhua correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT xuewei correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals
AT xuyunfei correctiontosunitinibsuppressedmir4525pfacilitatesrenalcancercellinvasionandmetastasisthroughmodulatingsmad4smad7signals